FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to compositions with modified release containing curcumin. Monolithic delayed release colon-specific pharmaceutical compositions for treating inflammatory, immunological and/or systemic origin intestinal disorders, contain a core containing hydroxypropyl methyl cellulose, where curcumin is dispersed; gastroresistant coating of nucleus, where weight ratio of curcumin to hydroxypropyl methyl cellulose is 3:1/2:1.
EFFECT: invention provides slow colon-free release of curcumin when used in matrix compositions of the present invention.
11 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MODIFIED-RELEASE THERAPEUTIC SYSTEMS FOR ORAL ADMINISTRATION OF MENTHOL IN THE TREATMENT OF INTESTINAL DISORDERS | 2014 |
|
RU2683645C1 |
| PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
| GASTRORESISTANT PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMIN | 2006 |
|
RU2403015C2 |
| COMBINED PREPARATION OF MOSAPRIDE AND RABEPRAZOLE | 2016 |
|
RU2697836C2 |
| TABLET WITH ENTEROSOLUBLE COATING AND METHOD OF PREPARING | 1998 |
|
RU2201217C2 |
| LACTOFERRIN FOR TREATING IBD CAUSED BY BACTERIAL INVASION | 2014 |
|
RU2689987C2 |
| COMPOSITION FOR USE IN TREATMENT OF INTESTINAL DAMAGE | 2017 |
|
RU2772870C2 |
| DOUBLE-LAYER VITAMIN B TABLETS AND A METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2732029C2 |
| TACROLIMUS FOR IMPROVED TREATMENT OF PATIENTS WITH GRAFTS | 2009 |
|
RU2574006C2 |
| MATRIX TABLET WITH MODIFIED NERAMEXANE RELEASE | 2006 |
|
RU2422135C2 |
